AstraZeneca beats top-line and bottom-line estimates; raises FY24 outlook
mohd izzuan/iStock by way of Getty Photographs AstraZeneca (NASDAQ:AZN) has raised its whole income and core ...
Read more
Tag: bottomline
Premium Content
Copyright © 2022 Real Invest Solutions.